Renal excretion of cimetidine
- PMID: 7205631
Renal excretion of cimetidine
Abstract
The renal excretion and certain pharmacokinetic properties of cimetidine were studied in anesthetized rats undergoing moderate osmotic diuresis. When cimetidine concentrations in plasma (Pcim) were low, ca. 2 micrograms/ml, the clearance of cimetidine (Ccim) was 2.64-fold greater than the glomerular filtration rate (GFR). Ccim was lower at higher concentrations, e.g., at ca. 200 micrograms/ml, Ccim/GFR was 1.24. When animals with low Pcim were alkalotic (bicarbonate infusion), Ccim/GFR was 1.82 (different from control, P less than 0.01). In nonalkalotic animals, Ccim/GFR was not influenced by changes in urine flow rate. High levels of Pcim completely blocked net secretion of the cation, tetraethylammonium ion, but did not inhibit the secretion of the anion p-aminohippurate. The half-time of cimetidine in plasma was 43 to 49 min. The apparent volume of distribution was 3.6-fold greater than estimated total body water. We conclude that cimetidine is secreted by the renal organic cation transport mechanism and that it probably undergoes passive reabsorption (nonionic diffusion) to a modest extent when the urine is alkaline. The relatively long half-life of the drug in the body, despite its very high renal clearance, is attributable to the large volume of distribution.
Similar articles
-
Renal tubular transport of cimetidine in the isolated perfused kidney of the rat.Drug Metab Dispos. 1994 Jan-Feb;22(1):148-53. Drug Metab Dispos. 1994. PMID: 8149875
-
Possible involvement of organic anion and cation transporters in renal excretion of xanthine derivatives, 3-methylxanthine and enprofylline.Life Sci. 2007 Sep 22;81(15):1175-82. doi: 10.1016/j.lfs.2007.07.032. Epub 2007 Aug 30. Life Sci. 2007. PMID: 17897683
-
Urinary excretion kinetics of famotidine in rats.Drug Metab Dispos. 1987 Mar-Apr;15(2):212-6. Drug Metab Dispos. 1987. PMID: 2882981
-
Prediction of human pharmacokinetics - renal metabolic and excretion clearance.J Pharm Pharmacol. 2007 Nov;59(11):1463-71. doi: 10.1211/jpp.59.11.0002. J Pharm Pharmacol. 2007. PMID: 17976256 Review.
-
Regulation of renal sodium and water excretion in the nephrotic syndrome and cirrhosis of the liver.Dan Med Bull. 1997 Apr;44(2):191-207. Dan Med Bull. 1997. PMID: 9151012 Review.
Cited by
-
Prediction of the renal clearance of cimetidine using endogenous N-1-methylnicotinamide.J Pharmacokinet Biopharm. 1991 Apr;19(2):175-88. doi: 10.1007/BF01073868. J Pharmacokinet Biopharm. 1991. PMID: 1826532
-
The use of the suicide CYP450 inhibitor ABT for distinguishing absorption and metabolism processes in in-vivo pharmacokinetic screens.Eur J Drug Metab Pharmacokinet. 2005 Jan-Jun;30(1-2):75-83. doi: 10.1007/BF03226411. Eur J Drug Metab Pharmacokinet. 2005. PMID: 16010865
-
Renal transport of drugs: an overview of methodology with application to cimetidine.Pharm Res. 1988 Aug;5(8):465-71. doi: 10.1023/a:1015904905235. Pharm Res. 1988. PMID: 3072557 Review.
-
Effects of probenecid and cimetidine on renal disposition of ofloxacin in rats.Antimicrob Agents Chemother. 1998 Feb;42(2):456-8. doi: 10.1128/AAC.42.2.456. Antimicrob Agents Chemother. 1998. PMID: 9527807 Free PMC article.
-
Selective inhibition of acetaminophen oxidation and toxicity by cimetidine and other histamine H2-receptor antagonists in vivo and in vitro in the rat and in man.J Clin Invest. 1984 Feb;73(2):383-91. doi: 10.1172/JCI111223. J Clin Invest. 1984. PMID: 6142056 Free PMC article.